These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

242 related items for PubMed ID: 19248174

  • 1. Promising diagnostic biomarkers for primary biliary cirrhosis identified with magnetic beads and MALDI-TOF-MS.
    Li YZ, Hu CJ, Leng XM, Zhao GF, Li N, Xu Y.
    Anat Rec (Hoboken); 2009 Mar; 292(3):455-60. PubMed ID: 19248174
    [Abstract] [Full Text] [Related]

  • 2. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of systemic lupus erythematosus.
    Huang Z, Shi Y, Cai B, Wang L, Wu Y, Ying B, Qin L, Hu C, Li Y.
    Rheumatology (Oxford); 2009 Jun; 48(6):626-31. PubMed ID: 19389822
    [Abstract] [Full Text] [Related]

  • 3. Construction of a multiple myeloma diagnostic model by magnetic bead-based MALDI-TOF mass spectrometry of serum and pattern recognition software.
    Wang QT, Li YZ, Liang YF, Hu CJ, Zhai YH, Zhao GF, Zhang J, Li N, Ni AP, Chen WM, Xu Y.
    Anat Rec (Hoboken); 2009 Apr; 292(4):604-10. PubMed ID: 19301277
    [Abstract] [Full Text] [Related]

  • 4. Detection of lung adenocarcinoma using magnetic beads based matrix-assisted laser desorption/ionization time-of-flight mass spectrometry serum protein profiling.
    Lin XL, Yang SY, Du J, Tian YX, Bu LN, Huo SF, Wang FP, Nan YD.
    Chin Med J (Engl); 2010 Jan 05; 123(1):34-9. PubMed ID: 20137572
    [Abstract] [Full Text] [Related]

  • 5. MALDI-TOF MS combined with magnetic beads for detecting serum protein biomarkers and establishment of boosting decision tree model for diagnosis of hepatocellular carcinoma.
    Liu C, Shen J, Pan C, Yang L, Mou S, Wang H, Liang Y.
    Am J Clin Pathol; 2010 Aug 05; 134(2):235-41. PubMed ID: 20660326
    [Abstract] [Full Text] [Related]

  • 6. Exploring serological classification tree model of active pulmonary tuberculosis by magnetic beads pretreatment and MALDI-TOF MS analysis.
    Deng C, Lin M, Hu C, Li Y, Gao Y, Cheng X, Zhang F, Dong M, Li Y.
    Scand J Immunol; 2011 Oct 05; 74(4):397-405. PubMed ID: 21668462
    [Abstract] [Full Text] [Related]

  • 7. [Study on proteomics of familial systemic lupus erythematosus patients in one family from Sichuan, China].
    Wu YK, Huang ZC, Shi YY, Cai B, Wang LL, Ying BW, Hu CJ, Li YZ.
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 May 05; 40(3):504-7, 512. PubMed ID: 19627015
    [Abstract] [Full Text] [Related]

  • 8. Serum protein profiling in patients with inflammatory bowel diseases using selective solid-phase bulk extraction, matrix-assisted laser desorption/ionization time-of-flight mass spectrometry and chemometric data analysis.
    Nanni P, Parisi D, Roda G, Casale M, Belluzzi A, Roda E, Mayer L, Roda A.
    Rapid Commun Mass Spectrom; 2007 May 05; 21(24):4142-8. PubMed ID: 18022963
    [Abstract] [Full Text] [Related]

  • 9. [Surface enhanced laser desorption/ionization time-of-flight mass spectrometry profiling of serum in detection of laryngeal squamous cell carcinoma and the progression to lymph node metastasis].
    Cheng L, Zhou L, Tao L, Zhang M, Cui JF, Liu YK.
    Zhonghua Yi Xue Za Zhi; 2007 Sep 25; 87(36):2526-30. PubMed ID: 18067823
    [Abstract] [Full Text] [Related]

  • 10. The potential biomarkers for thromboembolism detected by SELDI-TOF-MS.
    Hong M, Zhang X, Hu Y, Wang H, He W, Mei H, Yu J, Guo T, Song S.
    Thromb Res; 2009 Sep 25; 123(3):556-64. PubMed ID: 18620739
    [Abstract] [Full Text] [Related]

  • 11. Potential biomarkers for diagnosis of sarcoidosis using proteomics in serum.
    Bons JA, Drent M, Bouwman FG, Mariman EC, van Dieijen-Visser MP, Wodzig WK.
    Respir Med; 2007 Aug 25; 101(8):1687-95. PubMed ID: 17446058
    [Abstract] [Full Text] [Related]

  • 12. Specific serum protein biomarkers of rheumatoid arthritis detected by MALDI-TOF-MS combined with magnetic beads.
    Niu Q, Huang Z, Shi Y, Wang L, Pan X, Hu C.
    Int Immunol; 2010 Jul 25; 22(7):611-8. PubMed ID: 20497952
    [Abstract] [Full Text] [Related]

  • 13. SELDI-TOF MS proteinchip technology for screening of serum markers of HBV-induced hepatocellular carcinoma.
    Geng X, Wang F, Li YG, Zhu GP, Zhang WM.
    J Exp Clin Cancer Res; 2007 Dec 25; 26(4):505-8. PubMed ID: 18365545
    [Abstract] [Full Text] [Related]

  • 14. Behcet's disease with active uveitis: detection of serum protein biomarkers using MALDI-TOF-MS.
    Wang X, Zhang MF, Xie J, Li ZL, Wang P.
    Anat Rec (Hoboken); 2012 Jul 25; 295(7):1168-73. PubMed ID: 22641412
    [Abstract] [Full Text] [Related]

  • 15. Effect of surface-enhanced laser desorption/ionization time-of-flight mass spectrometry on identifing biomarkers of endometriosis.
    Zhang H, Feng J, Chang XH, Li ZX, Wu XY, Cui H.
    Chin Med J (Engl); 2009 Feb 20; 122(4):373-6. PubMed ID: 19302738
    [Abstract] [Full Text] [Related]

  • 16. Serum biomarkers of vascular cognitive impairment evaluated by bead-based proteomic technology.
    Xi L, Junjian Z, Yumin L, Yunwen L, Hongbin W.
    Neurosci Lett; 2009 Sep 29; 463(1):6-11. PubMed ID: 19631719
    [Abstract] [Full Text] [Related]

  • 17. Multiplexed immunoassay: quantitation and profiling of serum biomarkers using magnetic nanoprobes and MALDI-TOF MS.
    Wang KY, Chuang SA, Lin PC, Huang LS, Chen SH, Ouarda S, Pan WH, Lee PY, Lin CC, Chen YJ.
    Anal Chem; 2008 Aug 15; 80(16):6159-67. PubMed ID: 18642877
    [Abstract] [Full Text] [Related]

  • 18. A novel approach using MALDI-TOF/TOF mass spectrometry and prestructured sample supports (AnchorChip Technology) for proteomic profiling and protein identification.
    Leung SM, Pitts RL.
    Methods Mol Biol; 2008 Aug 15; 441():57-70. PubMed ID: 18370311
    [Abstract] [Full Text] [Related]

  • 19. Surface enhanced laser desorption/ionization profiling: New diagnostic method of HBV-related hepatocellular carcinoma.
    Wu C, Wang Z, Liu L, Zhao P, Wang W, Yao D, Shi B, Lu J, Liao P, Yang Y, Zhu L.
    J Gastroenterol Hepatol; 2009 Jan 15; 24(1):55-62. PubMed ID: 18823443
    [Abstract] [Full Text] [Related]

  • 20. Serum peptidome profiling revealed platelet factor 4 as a potential discriminating Peptide associated with pancreatic cancer.
    Fiedler GM, Leichtle AB, Kase J, Baumann S, Ceglarek U, Felix K, Conrad T, Witzigmann H, Weimann A, Schütte C, Hauss J, Büchler M, Thiery J.
    Clin Cancer Res; 2009 Jun 01; 15(11):3812-9. PubMed ID: 19470732
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.